金吾财讯 | 艾美疫苗(06660)公布，拟配售1550万股新H股予投资经理FMF，占扩大后的已发行H股股份数目的约3.05%及已发行股份数目的约1.26%。每股配售价5.01港元，较上交易日收市价6.26港元折让19.97%。配售事项集资7770万港元，净额7470万港元，拟将净额约60%用于加速公司多个产品线中各项临床前及临床项目的研发，包括开展多区域临床试验，以及用于建设基础设施和相关设施；约20%用于公司新产品的研发、营销及商业化；及约20%用于营运资金及其他企业用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.